Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 058023/0826 | |
| Pages: | 6 |
| | Recorded: | 11/04/2021 | | |
Attorney Dkt #: | 089885-0153 ET AL. |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
6
|
|
Patent #:
|
|
Issue Dt:
|
04/19/2011
|
Application #:
|
10202613
|
Filing Dt:
|
07/23/2002
|
Publication #:
|
|
Pub Dt:
|
01/29/2004
| | | | |
Title:
|
FAS LIGAND-AVIDIN/STREPTAVIDIN FUSION PROTEINS
|
|
|
Patent #:
|
|
Issue Dt:
|
10/06/2009
|
Application #:
|
11635066
|
Filing Dt:
|
12/07/2006
|
Publication #:
|
|
Pub Dt:
|
08/09/2007
| | | | |
Title:
|
IMMUNOSTIMULATORY COMPOSITIONS AND METHODS
|
|
|
Patent #:
|
|
Issue Dt:
|
12/13/2011
|
Application #:
|
11819080
|
Filing Dt:
|
06/25/2007
|
Publication #:
|
|
Pub Dt:
|
03/19/2009
| | | | |
Title:
|
ALTERATION OF CELL MEMBRANE WITH FASL
|
|
|
Patent #:
|
|
Issue Dt:
|
09/13/2011
|
Application #:
|
12553770
|
Filing Dt:
|
09/03/2009
|
Publication #:
|
|
Pub Dt:
|
06/24/2010
| | | | |
Title:
|
IMMUNOSTIMULATORY COMPOSITIONS AND METHODS
|
|
|
Patent #:
|
|
Issue Dt:
|
07/14/2015
|
Application #:
|
13227162
|
Filing Dt:
|
09/07/2011
|
Publication #:
|
|
Pub Dt:
|
07/05/2012
| | | | |
Title:
|
IMMUNOSTIMULATORY COMPOSITIONS AND METHODS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15736088
|
Filing Dt:
|
12/13/2017
|
Publication #:
|
|
Pub Dt:
|
11/08/2018
| | | | |
Title:
|
IMMUNOMODULATION FOR THE LONG TERM PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES AND FOREIGN TISSUE REJECTION
|
|
Assignees
|
|
|
300 E MARKET STREET |
SUITE 300 |
LOUISVILLE, KENTUCKY 40202 |
|
|
|
115 BUSINESS LOOP 70 WEST |
COLUMBIA, MISSOURI 65211-8375 |
|
Correspondence name and address
|
|
FOLEY & LARDNER LLP
|
|
3000 K STREET, N.W.
|
|
SUITE 600
|
|
WASHINGTON, DC 20007
|
Search Results as of:
05/10/2024 01:13 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|